Accelerating the Safe Hearts Plan: From Vision to Implementation

04 - 05 Nov 2026
+ 2026-11-04T00:00 2026-11-05T00:00 Europe/Paris Accelerating the Safe Hearts Plan: From Vision to Implementation
Add to calendar 2026-11-04T00:00 2026-11-05T00:00 Europe/Paris Accelerating the Safe Hearts Plan: From Vision to Implementation
CRT Onsite
At the heart of this gathering lies the main objective: to identify the actions needed to accelerate the implementation of the European Safe Hearts plan.
 
To achieve this, the meeting will pursue a focused set of preliminary objectives designed to bridge vision and execution:
  1. Identify the main barriers and enablers for implementing the Safe Hearts Plan across Europe
  2. Define priority actions to accelerate implementation at European, national and local levels.
  3. Discuss the roles of key stakeholders in supporting implementation.
  4. Identify tools to monitor progress, including key indicators and milestones.
  5. Share thoughts on the opportunity for extension to non-EU countries.
  6. Develop a position paper with practical recommendations and KPIs to accelerate implementation.

Programme

Day 1 – Wednesday, 4 November 2026

12:00 – 13:00: Arrivals and buffet lunch
 
13:00 – 13:05: Welcome from the CRT
Speakers: Bettina Kraus (BI) & Filippo Crea

Opening Session – CRT 25th Anniversary

13:05 – 13:30: What it took to start the CRT: looking back with ESC Leadership and Industry Partner
Speakers: Lars Ryden & Gunnar Olsson

13:35 – 15:00: Session 1.1 – Why Do We Need the Safe Hearts Plan?
Moderated By: Filippo Crea and Bettina Kraus (BI)

  • 13:35 – 13:50: Implementation of the Safe Hearts Plan: the EU perspective
    Speaker: TBC
  • 13:50 – 14:05: Implementation of the Safe Hearts Plan: the ESC and NCS perspectives
    Speaker: Susanna Price
  • 14:05 – 14:20: A patient view: patient needs, equity, health literacy and accountability in implementation
    Speaker: TBC
  • 14:20 – 14:35: Lessons learned from the Beating Cancer Plan
    Speaker: TBC
  • 14:35 – 15:00: Panel Discussion: What are the key expectations for the implementation?

15:00–15:30: Coffee break

15:30 - 16:30: Session 1.2 – What Are the Priorities?
Moderated By:   Susanna Price & Andrea Rappagliosi (Edwards Lifesciences)  

  • 15:30 – 15:45: Prevention across the life course
    Speaker: TBC
  • 15:45 – 16:00: Legislation opportunities in health prevention in terms of nicotine, food and alcohol
    Speaker: TBC
  • 16:00 – 16:15: Early detection through CV health checks
    Speaker: Maddalena Lettino
  • 16:15 – 16:30: Implementation of guideline-recommended treatment: the case of heart failure
    Speaker: TBC

16:30 – 16:40: Active break.

16:40 – 17:40: Breakout Sessions
Facilitator: Tamsin Rose

  • Group Discussions
    • Group 1:  How do we make health promotion and disease prevention happen – including the commercial determinants of health (food, alcohol, tobacco, environment)?  
      • Room:1&2
      • Lead: TBC
      • Rapporteur: TBC
    • Group 2:  How do we detect CVD earlier and reach underserved socio-economic groups?
      • Room:4&5
      • Lead: TBC
      • Rapporteur: TBC
    • Group 3: The opportunities of the Safe Hearts Plan to close implementation gaps through novel technologies
      • Room: Board Room
      • Lead: TBC
      • Rapporteur: TBC
  • 17:40 – 17:50: Report from Breakout Session 1
  • 17:50 – 18:00: Report from Breakout Session 2
  • 18:00 – 18:10: Report from Breakout Session 3
  • 18:10 – 18:25: Panel discussion: What are the priorities for implementation?

18:25 – 18:30: Wrap-up and outlook to day 2
Speaker: Tamsin Rose.

End Of Day 1

20:00: Bus Departures & Dinner

Day 2 – Thursday, 5 November 2026

08:30 – 09:30: Session 3-Enablers of Implementation
Moderated By: Victoria Tzouma (Amgen) and Bettina Kraus (BI)

  • 08:30 – 08:45: Primary care and the key role of allied health professionals
    speaker: TBC
  • 08:45 – 09:00: Data, indicators and monitoring: measuring inequalities within and between countries
    Speaker: Chris Gale
  • 09:00 – 09:15: Digital health, AI and technological innovations 
    Speaker: TBC
  • 09:15 – 09:30: EU financing opportunities and mechanisms
    Speaker: TBC

09:30 - 10:30: Session 4 – Building Partnerships and Extending the Reach
Moderated By: Mike Morrissey (MSD) and Susanna Price

  • 09:30 – 09:45: The role of the healthcare industry 
    Speaker: TBC
  • 09:45 – 10:00: An example of a funded national cardiovascular health plan
    Speaker: TBC
  • 10:00 – 10:15: Template for a national cardiovascular health plan: extending the work beyond the EU and opportunities for non-EU countries
    Speaker: Hector Bueno
  • 10:15 – 10:30: The leading role of politicians
    Speaker: TBC

10:30 – 10:40: Active break
10:40 – 11:00: Coffee break

11:00 – 11:45: Breakout sessions:  Outputs to be produced
Moderated By: Tasmin Rose

  • Group Discussions
    • Group 4: Suggestions for a national Cardiovascular Health Plan - Focus on financial and political aspects 
      • Room: Mike Morrissey 
      • Lead: TBC 
      • Rapporteur: TBC
    • Group 5: suggestions for a national cardiovascular health plan – focus on health promotion and disease prevention
      • Room:4&5 
      • Lead: TBC 
      • Rapporteur: TBC
    • Group 6: suggestions for a national cardiovascular health plan – focus on innovation and access
      • Room: Board Room 
      • Lead: TBC 
      • Rapporteur: TBC
  • 11:45 – 11:55: Report from Breakout Session 4
    Rapporteur: TBC
  • 11:55 – 12:05: Report from Breakout Session 5 
    Rapporteur: TBC
  • 12:05 – 12:15: Report from Breakout Session 6 
    Rapporteur: TBC
  • 12:15 – 12:35: Panel discussion: What should happen in the next 24 months?
  • 12:35 – 12:45: Fireside chat
    Speakers: Tamsin Rose & Hector Bueno
  • 12:45 – 12:50: Conclusion and farewell from the CRT Chairpersons.
    Speakers: Bettina Kraus (BI) & Filippo Crea

End Of Day 2

12:50: Buffet lunch and departures

Industry Chairpersons

Photo
Mr Mike Morrissey

MSD

Mr Andrea Rappagliosi

Edwards Lifesciences

Mrs Victoria Tzouma

Amgen

Photo
Doctor Bettina Kraus

Boehringer Ingelheim